Company Search:
Advanced Search
Sponsored Links
Polyphor AG Company Snapshot
Polyphor AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Polyphor AG with three other pharmaceutical manufacturers in Europe: Addex Therapeutics (2018 sales of 6.70 million Swiss Francs [US$6.76 million] of which 100% was Pharmaceuticals Manufacture), Biotec Pharmacon ASA of Norway (66.77 million Norwegian Kroner [US$7.44 million] of which 51% was Enzymes), and Onxeo SA which is based in France (6.13 million Euro [US$6.79 million] of which 91% was Operating segment -Rest of the world).

Sales Analysis.
  Stock Performance Chart for Polyphor AG
  Stock Data: Recent Stock Performance:
  Current Price (9/13/2019): 7.03
(Figures in Swiss Francs)
1 Week 34.9%   13 Weeks 57.4%  
4 Weeks -36.6%   52 Weeks -78.0%  
Polyphor AG Key Data:
  Ticker: POLN Country: Switzerland
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 6,545,595
(Year Ending Jan 2019).
Employees: N/A
  Currency: Swiss Francs Market Cap: 77,687,131
  Fiscal Yr Ends: December Shares Outstanding: 11,050,801
  Share Type: Ordinary Closely Held Shares: 5,174,168
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.